Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medtronic Announces FDA Approval Of SenSight Directional Lead System For Treating Movement Disorders

07 Jun 2021

• By Marion Webb

Brain

Related Content

Medtronic Bounces Back During Quarter Four Of Financial Year 2021 As Procedure Volumes Normalize

03 Jun 2021

Related Companies

Medtronic plc

Additional Topics

Approvals Commercial Clinical Trials Neurology Surgical Procedures Surgery Medical Device

More from Approvals

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.